Study: Widely-Used Nutritional Supplement Does Not Improve Cholesterol Levels
A new study suggests that use of the nutritional supplement policosanol does not lower cholesterol levels any more than placebo, apparently contradicting the results of previous studies.
Effect of Lowering Blood Pressure and Cholesterol on Risk for Cognitive Decline in Diabetics
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus.
Study Identifies Key Factor that Links Metabolic Syndrome
A new study led by researchers at Joslin Diabetes Center has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis.
Men May Be at Increased Risk of Peripheral Artery Disease When They Have Certain...
Among nearly 45,000 men who were followed up for more than two decades, those with the risk factors of smoking, hypertension, high cholesterol, and type 2 diabetes had an associated greater risk of developing PAD.
Statin Drugs and Risk of Advanced Prostate Cancer
Statins are commonly prescribed agents to lower cholesterol and the associated risks of vascular events. Statins are also known to have proapoptotic and antimetastatic effects in cancer.
Nearly Half of People Who Need Cholesterol Treatment Don’t Get It
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment.
World’s Largest Cholesterol-Lowering Trial Reveals Massive Benefits for High-Risk Patients
Around a third of all heart attacks and strokes can be avoided in people at risk of vascular disease by using statin drugs to lower blood cholesterol levels – irrespective of the person’s age or sex, and even if their cholesterol levels do not seem high.
Fat in the Liver, Not the Belly, is a Better Marker for Disease Risk
New findings suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Stanford Researcher Studies Newly Discovered ‘Good’ Cholesterol Gene
Study could lead to new therapies for heart disease.
Researchers: Statin Users Risk Heart Attacks by Dropping Treatment or Taking Low Doses
Thousands of statin users worldwide are suffering preventable heart attacks, simply because they are not complying with their treatment or are taking too low a dose, according to new research.
Pesticide Exposure in Womb Linked to Slow Metabolism, Obesity and Diabetes
The study is the first to show that developmental exposure increases the risk of females later developing metabolic syndrome -- a cluster of conditions that include increased body fat, blood glucose, and cholesterol.
Sugar Industry Cherry Picked Data to Blame Fat for CHD
A disturbing report published by JAMA details the lengths the sugar industry has gone to since the 1950's to cast fat as the cause...
No Good Evidence That Cholesterol Drugs Lower Melanoma Risk
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
Study: Substances In Grapefruit Juice Interact Dangerously With Some Drugs
New research has identified and established the substance in grapefruit juice that causes potentially dangerous interactions with certain medications.
Scientists Find Protein May Be Key to New Therapies for Elevated Triglycerides
Researchers have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic.
Substance in Tangerines Fights Obesity and Protects Against Heart Disease
New research has discovered a substance in tangerines not only prevents obesity, but also offers protection against type 2 diabetes, and even atherosclerosis.
